Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001839882-24-039023
Filing Date
2024-11-14
Accepted
2024-11-14 09:19:50
Documents
2
Group Members
ALTIUM GROWTH FUND, LPALTIUM GROWTH GP, LLC

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO FORM SC 13G ep-sc13ga_093024.htm SC 13G/A 73507
2 JOINT ACQUISITION STATEMENT ex1.htm EX-1 6649
  Complete submission text file 0001839882-24-039023.txt   81784
Mailing Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Subject) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87872 | Film No.: 241457717
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 152 W 57 ST FL20 NEW YORK NY 10019
Business Address 152 W 57 ST FL20 NEW YORK NY 10019 2124842711
Altium Capital Management LP (Filed by) CIK: 0001746382 (see all company filings)

EIN.: 822066653 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A